Medical Care

Global Ocular Hypertension Treatment Market Research Report 2024

Ocular hypertension is caused by poor drainage of the fluid inside the eye. Essentially, this means that too much fluid enters the eye without being drained, causing high amount of pressure to build up.
The global Ocular Hypertension Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Ocular Hypertension Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ocular Hypertension Treatment.
Report Scope
The Ocular Hypertension Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ocular Hypertension Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ocular Hypertension Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Aerie Pharmaceuticals, Inc.
Allergan plc
Angelini Group
Chong Kun Dang Pharmaceutical Corp.
SALVAT SA
Sophia SA de CV
Lee's Pharmaceutical Holdings Ltd.
Neurim Pharmaceuticals Ltd.
NicOx SA
Novartis AG
Segment by Type
Intraocular Hypertension
Glaucoma
Segment by Application
Hospitals
Specialty Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ocular Hypertension Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ocular Hypertension Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Intraocular Hypertension
1.2.3 Glaucoma
1.3 Market by Application
1.3.1 Global Ocular Hypertension Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Ocular Hypertension Treatment Market Perspective (2019-2030)
2.2 Ocular Hypertension Treatment Growth Trends by Region
2.2.1 Global Ocular Hypertension Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Ocular Hypertension Treatment Historic Market Size by Region (2019-2024)
2.2.3 Ocular Hypertension Treatment Forecasted Market Size by Region (2025-2030)
2.3 Ocular Hypertension Treatment Market Dynamics
2.3.1 Ocular Hypertension Treatment Industry Trends
2.3.2 Ocular Hypertension Treatment Market Drivers
2.3.3 Ocular Hypertension Treatment Market Challenges
2.3.4 Ocular Hypertension Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ocular Hypertension Treatment Players by Revenue
3.1.1 Global Top Ocular Hypertension Treatment Players by Revenue (2019-2024)
3.1.2 Global Ocular Hypertension Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Ocular Hypertension Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Ocular Hypertension Treatment Revenue
3.4 Global Ocular Hypertension Treatment Market Concentration Ratio
3.4.1 Global Ocular Hypertension Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ocular Hypertension Treatment Revenue in 2023
3.5 Ocular Hypertension Treatment Key Players Head office and Area Served
3.6 Key Players Ocular Hypertension Treatment Product Solution and Service
3.7 Date of Enter into Ocular Hypertension Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Ocular Hypertension Treatment Breakdown Data by Type
4.1 Global Ocular Hypertension Treatment Historic Market Size by Type (2019-2024)
4.2 Global Ocular Hypertension Treatment Forecasted Market Size by Type (2025-2030)
5 Ocular Hypertension Treatment Breakdown Data by Application
5.1 Global Ocular Hypertension Treatment Historic Market Size by Application (2019-2024)
5.2 Global Ocular Hypertension Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Ocular Hypertension Treatment Market Size (2019-2030)
6.2 North America Ocular Hypertension Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Ocular Hypertension Treatment Market Size by Country (2019-2024)
6.4 North America Ocular Hypertension Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Ocular Hypertension Treatment Market Size (2019-2030)
7.2 Europe Ocular Hypertension Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Ocular Hypertension Treatment Market Size by Country (2019-2024)
7.4 Europe Ocular Hypertension Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Ocular Hypertension Treatment Market Size (2019-2030)
8.2 Asia-Pacific Ocular Hypertension Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Ocular Hypertension Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Ocular Hypertension Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Ocular Hypertension Treatment Market Size (2019-2030)
9.2 Latin America Ocular Hypertension Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Ocular Hypertension Treatment Market Size by Country (2019-2024)
9.4 Latin America Ocular Hypertension Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ocular Hypertension Treatment Market Size (2019-2030)
10.2 Middle East & Africa Ocular Hypertension Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Ocular Hypertension Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Ocular Hypertension Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Aerie Pharmaceuticals, Inc.
11.1.1 Aerie Pharmaceuticals, Inc. Company Detail
11.1.2 Aerie Pharmaceuticals, Inc. Business Overview
11.1.3 Aerie Pharmaceuticals, Inc. Ocular Hypertension Treatment Introduction
11.1.4 Aerie Pharmaceuticals, Inc. Revenue in Ocular Hypertension Treatment Business (2019-2024)
11.1.5 Aerie Pharmaceuticals, Inc. Recent Development
11.2 Allergan plc
11.2.1 Allergan plc Company Detail
11.2.2 Allergan plc Business Overview
11.2.3 Allergan plc Ocular Hypertension Treatment Introduction
11.2.4 Allergan plc Revenue in Ocular Hypertension Treatment Business (2019-2024)
11.2.5 Allergan plc Recent Development
11.3 Angelini Group
11.3.1 Angelini Group Company Detail
11.3.2 Angelini Group Business Overview
11.3.3 Angelini Group Ocular Hypertension Treatment Introduction
11.3.4 Angelini Group Revenue in Ocular Hypertension Treatment Business (2019-2024)
11.3.5 Angelini Group Recent Development
11.4 Chong Kun Dang Pharmaceutical Corp.
11.4.1 Chong Kun Dang Pharmaceutical Corp. Company Detail
11.4.2 Chong Kun Dang Pharmaceutical Corp. Business Overview
11.4.3 Chong Kun Dang Pharmaceutical Corp. Ocular Hypertension Treatment Introduction
11.4.4 Chong Kun Dang Pharmaceutical Corp. Revenue in Ocular Hypertension Treatment Business (2019-2024)
11.4.5 Chong Kun Dang Pharmaceutical Corp. Recent Development
11.5 SALVAT SA
11.5.1 SALVAT SA Company Detail
11.5.2 SALVAT SA Business Overview
11.5.3 SALVAT SA Ocular Hypertension Treatment Introduction
11.5.4 SALVAT SA Revenue in Ocular Hypertension Treatment Business (2019-2024)
11.5.5 SALVAT SA Recent Development
11.6 Sophia SA de CV
11.6.1 Sophia SA de CV Company Detail
11.6.2 Sophia SA de CV Business Overview
11.6.3 Sophia SA de CV Ocular Hypertension Treatment Introduction
11.6.4 Sophia SA de CV Revenue in Ocular Hypertension Treatment Business (2019-2024)
11.6.5 Sophia SA de CV Recent Development
11.7 Lee's Pharmaceutical Holdings Ltd.
11.7.1 Lee's Pharmaceutical Holdings Ltd. Company Detail
11.7.2 Lee's Pharmaceutical Holdings Ltd. Business Overview
11.7.3 Lee's Pharmaceutical Holdings Ltd. Ocular Hypertension Treatment Introduction
11.7.4 Lee's Pharmaceutical Holdings Ltd. Revenue in Ocular Hypertension Treatment Business (2019-2024)
11.7.5 Lee's Pharmaceutical Holdings Ltd. Recent Development
11.8 Neurim Pharmaceuticals Ltd.
11.8.1 Neurim Pharmaceuticals Ltd. Company Detail
11.8.2 Neurim Pharmaceuticals Ltd. Business Overview
11.8.3 Neurim Pharmaceuticals Ltd. Ocular Hypertension Treatment Introduction
11.8.4 Neurim Pharmaceuticals Ltd. Revenue in Ocular Hypertension Treatment Business (2019-2024)
11.8.5 Neurim Pharmaceuticals Ltd. Recent Development
11.9 NicOx SA
11.9.1 NicOx SA Company Detail
11.9.2 NicOx SA Business Overview
11.9.3 NicOx SA Ocular Hypertension Treatment Introduction
11.9.4 NicOx SA Revenue in Ocular Hypertension Treatment Business (2019-2024)
11.9.5 NicOx SA Recent Development
11.10 Novartis AG
11.10.1 Novartis AG Company Detail
11.10.2 Novartis AG Business Overview
11.10.3 Novartis AG Ocular Hypertension Treatment Introduction
11.10.4 Novartis AG Revenue in Ocular Hypertension Treatment Business (2019-2024)
11.10.5 Novartis AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Ocular Hypertension Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Intraocular Hypertension
Table 3. Key Players of Glaucoma
Table 4. Global Ocular Hypertension Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Ocular Hypertension Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Ocular Hypertension Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Ocular Hypertension Treatment Market Share by Region (2019-2024)
Table 8. Global Ocular Hypertension Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Ocular Hypertension Treatment Market Share by Region (2025-2030)
Table 10. Ocular Hypertension Treatment Market Trends
Table 11. Ocular Hypertension Treatment Market Drivers
Table 12. Ocular Hypertension Treatment Market Challenges
Table 13. Ocular Hypertension Treatment Market Restraints
Table 14. Global Ocular Hypertension Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Ocular Hypertension Treatment Market Share by Players (2019-2024)
Table 16. Global Top Ocular Hypertension Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ocular Hypertension Treatment as of 2023)
Table 17. Ranking of Global Top Ocular Hypertension Treatment Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Ocular Hypertension Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Ocular Hypertension Treatment Product Solution and Service
Table 21. Date of Enter into Ocular Hypertension Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Ocular Hypertension Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Ocular Hypertension Treatment Revenue Market Share by Type (2019-2024)
Table 25. Global Ocular Hypertension Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Ocular Hypertension Treatment Revenue Market Share by Type (2025-2030)
Table 27. Global Ocular Hypertension Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Ocular Hypertension Treatment Revenue Market Share by Application (2019-2024)
Table 29. Global Ocular Hypertension Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Ocular Hypertension Treatment Revenue Market Share by Application (2025-2030)
Table 31. North America Ocular Hypertension Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Ocular Hypertension Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Ocular Hypertension Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Ocular Hypertension Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Ocular Hypertension Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Ocular Hypertension Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Ocular Hypertension Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Ocular Hypertension Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Ocular Hypertension Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Ocular Hypertension Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Ocular Hypertension Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Ocular Hypertension Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Ocular Hypertension Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Ocular Hypertension Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Ocular Hypertension Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 46. Aerie Pharmaceuticals, Inc. Company Detail
Table 47. Aerie Pharmaceuticals, Inc. Business Overview
Table 48. Aerie Pharmaceuticals, Inc. Ocular Hypertension Treatment Product
Table 49. Aerie Pharmaceuticals, Inc. Revenue in Ocular Hypertension Treatment Business (2019-2024) & (US$ Million)
Table 50. Aerie Pharmaceuticals, Inc. Recent Development
Table 51. Allergan plc Company Detail
Table 52. Allergan plc Business Overview
Table 53. Allergan plc Ocular Hypertension Treatment Product
Table 54. Allergan plc Revenue in Ocular Hypertension Treatment Business (2019-2024) & (US$ Million)
Table 55. Allergan plc Recent Development
Table 56. Angelini Group Company Detail
Table 57. Angelini Group Business Overview
Table 58. Angelini Group Ocular Hypertension Treatment Product
Table 59. Angelini Group Revenue in Ocular Hypertension Treatment Business (2019-2024) & (US$ Million)
Table 60. Angelini Group Recent Development
Table 61. Chong Kun Dang Pharmaceutical Corp. Company Detail
Table 62. Chong Kun Dang Pharmaceutical Corp. Business Overview
Table 63. Chong Kun Dang Pharmaceutical Corp. Ocular Hypertension Treatment Product
Table 64. Chong Kun Dang Pharmaceutical Corp. Revenue in Ocular Hypertension Treatment Business (2019-2024) & (US$ Million)
Table 65. Chong Kun Dang Pharmaceutical Corp. Recent Development
Table 66. SALVAT SA Company Detail
Table 67. SALVAT SA Business Overview
Table 68. SALVAT SA Ocular Hypertension Treatment Product
Table 69. SALVAT SA Revenue in Ocular Hypertension Treatment Business (2019-2024) & (US$ Million)
Table 70. SALVAT SA Recent Development
Table 71. Sophia SA de CV Company Detail
Table 72. Sophia SA de CV Business Overview
Table 73. Sophia SA de CV Ocular Hypertension Treatment Product
Table 74. Sophia SA de CV Revenue in Ocular Hypertension Treatment Business (2019-2024) & (US$ Million)
Table 75. Sophia SA de CV Recent Development
Table 76. Lee's Pharmaceutical Holdings Ltd. Company Detail
Table 77. Lee's Pharmaceutical Holdings Ltd. Business Overview
Table 78. Lee's Pharmaceutical Holdings Ltd. Ocular Hypertension Treatment Product
Table 79. Lee's Pharmaceutical Holdings Ltd. Revenue in Ocular Hypertension Treatment Business (2019-2024) & (US$ Million)
Table 80. Lee's Pharmaceutical Holdings Ltd. Recent Development
Table 81. Neurim Pharmaceuticals Ltd. Company Detail
Table 82. Neurim Pharmaceuticals Ltd. Business Overview
Table 83. Neurim Pharmaceuticals Ltd. Ocular Hypertension Treatment Product
Table 84. Neurim Pharmaceuticals Ltd. Revenue in Ocular Hypertension Treatment Business (2019-2024) & (US$ Million)
Table 85. Neurim Pharmaceuticals Ltd. Recent Development
Table 86. NicOx SA Company Detail
Table 87. NicOx SA Business Overview
Table 88. NicOx SA Ocular Hypertension Treatment Product
Table 89. NicOx SA Revenue in Ocular Hypertension Treatment Business (2019-2024) & (US$ Million)
Table 90. NicOx SA Recent Development
Table 91. Novartis AG Company Detail
Table 92. Novartis AG Business Overview
Table 93. Novartis AG Ocular Hypertension Treatment Product
Table 94. Novartis AG Revenue in Ocular Hypertension Treatment Business (2019-2024) & (US$ Million)
Table 95. Novartis AG Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ocular Hypertension Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Ocular Hypertension Treatment Market Share by Type: 2023 VS 2030
Figure 3. Intraocular Hypertension Features
Figure 4. Glaucoma Features
Figure 5. Global Ocular Hypertension Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Ocular Hypertension Treatment Market Share by Application: 2023 VS 2030
Figure 7. Hospitals Case Studies
Figure 8. Specialty Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Ocular Hypertension Treatment Report Years Considered
Figure 11. Global Ocular Hypertension Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Ocular Hypertension Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Ocular Hypertension Treatment Market Share by Region: 2023 VS 2030
Figure 14. Global Ocular Hypertension Treatment Market Share by Players in 2023
Figure 15. Global Top Ocular Hypertension Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ocular Hypertension Treatment as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Ocular Hypertension Treatment Revenue in 2023
Figure 17. North America Ocular Hypertension Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Ocular Hypertension Treatment Market Share by Country (2019-2030)
Figure 19. United States Ocular Hypertension Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Ocular Hypertension Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Ocular Hypertension Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Ocular Hypertension Treatment Market Share by Country (2019-2030)
Figure 23. Germany Ocular Hypertension Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Ocular Hypertension Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Ocular Hypertension Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Ocular Hypertension Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Ocular Hypertension Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Ocular Hypertension Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Ocular Hypertension Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Ocular Hypertension Treatment Market Share by Region (2019-2030)
Figure 31. China Ocular Hypertension Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Ocular Hypertension Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Ocular Hypertension Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Ocular Hypertension Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Ocular Hypertension Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Ocular Hypertension Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Ocular Hypertension Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Ocular Hypertension Treatment Market Share by Country (2019-2030)
Figure 39. Mexico Ocular Hypertension Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Ocular Hypertension Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Ocular Hypertension Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Ocular Hypertension Treatment Market Share by Country (2019-2030)
Figure 43. Turkey Ocular Hypertension Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Ocular Hypertension Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Aerie Pharmaceuticals, Inc. Revenue Growth Rate in Ocular Hypertension Treatment Business (2019-2024)
Figure 46. Allergan plc Revenue Growth Rate in Ocular Hypertension Treatment Business (2019-2024)
Figure 47. Angelini Group Revenue Growth Rate in Ocular Hypertension Treatment Business (2019-2024)
Figure 48. Chong Kun Dang Pharmaceutical Corp. Revenue Growth Rate in Ocular Hypertension Treatment Business (2019-2024)
Figure 49. SALVAT SA Revenue Growth Rate in Ocular Hypertension Treatment Business (2019-2024)
Figure 50. Sophia SA de CV Revenue Growth Rate in Ocular Hypertension Treatment Business (2019-2024)
Figure 51. Lee's Pharmaceutical Holdings Ltd. Revenue Growth Rate in Ocular Hypertension Treatment Business (2019-2024)
Figure 52. Neurim Pharmaceuticals Ltd. Revenue Growth Rate in Ocular Hypertension Treatment Business (2019-2024)
Figure 53. NicOx SA Revenue Growth Rate in Ocular Hypertension Treatment Business (2019-2024)
Figure 54. Novartis AG Revenue Growth Rate in Ocular Hypertension Treatment Business (2019-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies